We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » COX-2 CRACKDOWN JEOPARDIZING BENEFICIAL RESEARCH, EXPERTS SAY
COX-2 CRACKDOWN JEOPARDIZING BENEFICIAL RESEARCH, EXPERTS SAY
January 17, 2005
Mounting concerns over the safety of Cox-2 inhibitors is having a negative impact on medical research, including large studies on the prevention and treatment of cancer, rheumatoid arthritis and osteoarthritis, dementia, and other diseases, industry experts warn.